We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Immunodiagnostic Systems Showcases Next-Gen Immunoanalyzer at AACC

By LabMedica International staff writers
Posted on 31 Jul 2018
Immunodiagnostic Systems (Tyne & Wear, UK) showcased its next generation immunoanalyzer, the IDS-i10, at the AACC annual meeting and exhibition, the world’s largest scientific conference and tradeshow in the laboratory medicine field. More...
This year marked the 70th edition of the scientific meeting and clinical lab expo, hosted in McCormick Place, in Chicago, USA.

The exhibition provided a platform to connect with the world’s thought leaders in breaking laboratory medicine operating in fields, including clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine and lab management. The tradeshow was full of technological advances as over 200 new product introductions were unveiled and demonstrated. Additionally, research developments and changes in the laboratory medicine field were discussed in a variety of clinical areas through an educational experience, which could be tailored by selecting from a range of scientific sessions.

Immunodiagnostic Systems is a provider of in-vitro diagnostic solution to the clinical laboratory market. The company develops, manufactures and markets immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. Its immunoassay portfolio is a combination of an endocrinology specialty-testing menu and assay panels in complementary fields.

At AACC 2018, Immunodiagnostic Systems showcased its new IDS-i10 immunoanalyzer with faster testing capability and the capacity to connect to laboratory track systems. The instrument is designed to help medical professionals perform automated immunoassays more efficiently than ever. The company also discussed its automated and manual assay panels, with its experts available at the event to assist with queries from the attendees.

Related Links:
Immunodiagnostic Systems


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Chromogenic Culture System
InTray™ COLOREX™ ECC
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.